BEYOND GENOMiX SA

Scalable ML-empowered platform for aging hallmarks analysis

BEYOND GENOMiX is a Swiss deeptech company developing the world’s first integrated platform for the measurement and integration of biological aging hallmarks. The company builds advanced measurement tools that convert complex aging processes into high-resolution, clinically actionable data, with an initial focus on telomere measurement using world-leading, clinically validated technologies enabling single-cell and nucleotide-level analysis from low-volume samples. The platform supports diagnostic applications in age-related diseases, including a first clinically validated test in reproductive health. Deployed at clinical scale, it generates disease-specific datasets analysed using proprietary machine-learning algorithms to support clinical decision-making, patient stratification, drug disc

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.

No news

No milestones

No Jobs

No videos and documents

No Awards

BEYOND GENOMiX SA

Scalable ML-empowered platform for aging hallmarks analysis

Headquarter:
Neuchâtel

Foundation Date:
March 2023

Technology:

  • Medtech

Sectors:

  • Digital Health
  • Diagnostics
  • Machine Learning / AI
  • Software